4LBA - A systematic liquid biopsy program identifies novel and heterogeneous mechanisms of acquired resistance in gastrointestinal (GI) cancer patients.

Saved in:
Bibliographic Details
Title: 4LBA - A systematic liquid biopsy program identifies novel and heterogeneous mechanisms of acquired resistance in gastrointestinal (GI) cancer patients.
Authors: Parikh, A., Kwak, E., Goyal, L., Blaszkowsky, L., Hazar-Rethinam, M., Siravegna, G., Russo, M., Van Seventer, E., Nadres, B., Shahzade, H., Clark, J., Allen, J., Iafrate, A.J., Bardellli, A., Ryan, D., Murphy, J., Zhu, A., Hong, T., Corcoran, R.
Source: European Journal of Cancer. Dec2016 Supplement 1, Vol. 69, pS3-S3. 1p.
Database: Academic Search Ultimate
Description
ISSN:09598049
DOI:10.1016/S0959-8049(16)32610-7